Functional protection and long-term survival of renal allograft by the combination of ACE inhibitor and angiotensin receptor blocker
- VernacularTitle:缬沙坦与贝那普利联用治疗移植肾慢性损伤的远期效果
- Author:
Junjie MA
;
Zehong GUI
;
Lijun XU
;
Lixin YU
;
Ronghua CAO
;
Guobao WANG
;
Haifeng YANG
- Publication Type:Journal Article
- Keywords:
Kidney transplantation;
Nephropathy;
Angiotensins
- From:
Chinese Journal of Urology
2008;29(8):547-549
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the role of the combination of angiotensin receptor blocker (ARB)and angiotensin corwerting enzyme inhibitor(ACEI)in functional protection and long-term survival of renal allograft. Methods Thirty-two renal transplant recipients without diabetes mellitus,whose albuminuria concentration in 24-hours collection was more than 0.5 g/d or serum Cr concentration was higher than 177 mmol/L,were randomly divided into experimental group(n=23,male 9 and female 14 cases,mean age 40 years)and control group(n=9,male 5 and female 4 cases,mean age 35 years).Combination of ARB(Valsartan,80rag Qd)and ACEI(Benazapril,20 mg Bid)theraPy was given to each patient every day for 3 years in experimental group.The recipients in control group never received this administration.The serum Cr concentration,albuminuria in 24-hours collection and survival of renal allograft were compared between the 2 groups after 3 years. Results There was significant difference(P＜0.05) of serum Cr concentration between experimental group and control group(252.2±117.9 mmol/L VS 375.3±203.0 mmol/L),especially for chronic allograft nephropathy (CAN)patieats(282.4±147.3 mmol/L vs 528.7±107.8 mmol/L,P＜0.01).There was no difference (P＞0.05)in terms of the values of alburninuria(1.0±0.6 g/d vs 1.3±0.7 g/d)and survival of renal allograft(76 months VS 71 months)after 3 years between 2 groups.Comclusion The administration of ARB+ACEI could protect function of renal allograft with different pathological changes especially for CAN.
